MEDICARE, FDA & OTHER HEALTH ISSUES

0
Rate this post

PAN remains to be a number one voice for affected person advocacy in Washington, DC operating in coalition on essential problems similar to Medicare drug protection and repayment, in addition to quicker evaluation via the FDA for leading edge treatments and reauthorization of the Prescription Drug Consumer Price Act.